Karyopharm Therapeutics' (KPTI) CEO Michael Kauffman on Q3 2016 Results - Earnings Call Transcript

11/8/16

Karyopharm Therapeutics Inc. (NASDAQ:KPTI)

Q3 2016 Earnings Conference Call

November 7, 2016 5:00 PM ET

Executives

Justin Renz – Executive Vice President, Chief Financial Officer and Treasurer

Michael Kauffman – Chief Executive Officer

Sharon Shacham – President and Chief Scientific Officer

Analysts

Brian Abrahams – Jefferies

Whitney Ijem – JPMorgan

Michael Schmidt – Leerink Partners

Laura Chico – Raymond James

Michael King – JMP Securities

Jenny Leeds – Bank of America Merrill Lynch

Arlinda Lee – Canaccord Genuity

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.